WILMINGTON, DE — Inhibikase Therapeutics (Nasdaq: IKT) granted stock options covering 981,243 shares of common stock to seven newly hired non-executive employees under its 2026 Inducement Equity Plan, the company …
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.